13D Filings

GMS VENTURES & INVESTMENTS

CIK

1804598

13D Filings

5

Companies

1

Latest Filing

Aug 14, 2026, 07:54 PM

Filing History
Company
% Owned
Type
Filed
Outlook Therapeutics, Inc.
OTLK

16.40%

-6.50%

Amendment

Aug 14, 2026, 07:54 PM

Outlook Therapeutics, Inc.
OTLK

22.90%

-27.40%

Amendment

Jun 1, 2026, 09:31 PM

Outlook Therapeutics, Inc.
OTLK

50.30%

+8.70%

Amendment

May 28, 2025, 05:24 PM

Outlook Therapeutics, Inc.
OTLK

41.60%

+3.00%

Amendment

Mar 12, 2025, 09:11 PM

Outlook Therapeutics, Inc.
OTLK

38.60%

Amendment

Jan 22, 2025, 04:17 PM

Rows:

15 of 5

1